Scaling Patient Safety through Innovation

Bio: Michael Braun-Boghos

Michael has been working in medicinal product safety for the last three decades. He spent 13 years at the European PV headquarters of Fujisawa, which later became Astellas, ultimately leading the Safety Data and Quality Management group. Thereafter he joined Relsys, the developer of the Argus software, and finally came to Oracle with the Relsys acquisition in 2009. As a senior director in the safety strategy team, he helps drive the product roadmap of the Oracle Safety One Platform including Argus, Empirica, Safety One Intake, and Oracle Analytics.

Bio: Cheryl James

Cheryl James has worked at a senior level within the pharmaceutical industry for over 15 years, building extensive business knowledge and implementation experience with the Oracle Life Sciences suite, specifically AERS and now Argus Safety.

In her role as Director of Safety Analytics for PharmaLex (formerly pharmasol), Cheryl has been instrumental in developing the Argus components that have culminated in the industry-leading rapidLIVE – PharmaLex’s accelerated, pre-packaged implementation for Oracle Argus.

Cheryl was first appointed as Director of Pharmacovigilance for pharmasol in 2008, joining from Oracle, where she served as Senior Life Sciences Consultant specialising in AERS. Prior to Oracle, she held the position of Principal Pharmacovigilance Scientist within the newly created Pharmacovigilance group at PPD, a global CRO. This role provided the opportunity to develop invaluable interdisciplinary experience across numerous Oracle applications and multiple drug safety systems. Previously, Cheryl worked as part of a research group within a cutting-edge medical centre, sparking her career-long interest in drug safety.

Cheryl holds a BSc in Biology and Psychology from the University of Bristol.